Characterization of low density lipoprotein receptor (LDLR) gene mutations in Albania. 2010

Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.

BACKGROUND Familial hypercholesterolaemia (FH) is a clinical syndrome characterised by elevated serum total cholesterol (TCHOL) levels due to an increase in low-density lipoprotein (LDL) cholesterol, by tendon xanthomata and clinical manifestations of ischaemic heart disease in early life. Typically, it results from mutations in the low-density lipoprotein receptor (LDLR) gene. So far, more than 800 mutations have been reported for the LDLR gene and account for FH. The nature of LDLR gene mutations varies among different ethnicities. Until now no mutations of LDLR have been reported in the Albanian population. METHODS We assessed the contribution of the LDLR gene mutations as causes of FH in an Albanian population. Fifty probands with a clinical diagnosis of FH were included. We analysed all the exons and the promoter of the LDLR gene by using restriction isotyping or direct sequencing. RESULTS Twenty-one patients were heterozygous for the 1646G>A mutation (FH Genoa) in exon 11 and 9 patients were heterozygous for the 81T>C mutation in exon 2 of the LDLR gene. CONCLUSIONS This report describes two LDLR gene mutations accounting for FH in Albania (1646G>A, 81T>C).

UI MeSH Term Description Entries

Related Publications

Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
May 2001, Human mutation,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
July 1988, Nucleic acids research,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
January 1989, Nucleic acids research,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
January 1987, Nucleic acids research,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
February 1989, Nucleic acids research,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
October 2001, Human mutation,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
March 2012, The Yale journal of biology and medicine,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
May 2018, Arteriosclerosis, thrombosis, and vascular biology,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
May 2022, Vavilovskii zhurnal genetiki i selektsii,
Maria Diakou, and George Miltiadous, and Stavroula Xenophontos, and Marios Cariolou, and Nevila Heta, and Irena Korita, and Anyla Bulo, and Etleva Refatllari, and Eleni Bairaktari, and Moses Elisaf
July 2006, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!